3 ms·
From the article: "Beyond the matter of convenience, if Athelas doesn’t integrate seamlessly into existing electronic medical-record systems, most doctors woul
by sk5t 9y ago
From the article:
"Beyond the matter of convenience, if Athelas doesn’t integrate seamlessly into existing electronic medical-record systems, most doctors would reject it because they don’t want to deal with separate software[...]"
Devices, FDA, and insurance reimbursement aside, is $3.7MM enough capital to try to start addressing even this task?
- jdmichal 9y agoI'm pretty sure that's in "definitely not" territory. I would expect that initial funding to go towards productizing the actual blood tests -- I'm assuming they're at more or less proof-of-concept level at this point. That would be enough to get some sales to individual offices without large records systems and maybe even some overseas and doctors-without-borders types. I would expect larger rounds of follow-on funding to enable those larger integrations, which would then open up the large practices and hospitals. Also, more pessimistically, I don't think less than $4m is even enough to start courting all the admins that would need to be greased to get large hospital sales, even if all the tech existed...
- sk5t 9y agoThanks--I actually posted to try to verify or reject my own biases: as software lead for a startup focusing on LDTs, I've been ruthless about shooting down any suggestion to veer towards EMR/EHR integration as very likely lethal to a fledgling business.